Bacterial porins stimulate bone resorption.
Porins are abundant outer membrane proteins of gram-negative bacteria involved in transport of low-molecular-mass molecules. During the past decade, porins from a number of bacteria have also been shown to have proinflammatory activities including inducing the synthesis of proinflammatory mediators (cytokines, platelet-activating factor, and nitric oxide) in cultured cells and inducing inflammation in vivo. With this range of actions, it was possible that porins could also interact with bone cells to cause aberrant bone remodeling and that this could contribute to the bone destruction seen in gram-negative bone infections. By using purified preparations of Salmonella typhimurium and Pseudomonas aeruginosa porins, in the presence of polymyxin B, it was possible to induce concentration-dependent loss of calcium from cultured murine calvaria at porin concentrations in the range of 1 to 10 nM. The mechanism of action of the porins was determined by the inclusion of inhibitors of cyclooxygenase or inflammatory cytokines in the culture media. The bone-resorbing activity of both porins was not inhibited by the cyclooxygenase inhibitor indomethacin or by neutralizing the activity of tumor necrosis factor. Indeed, relatively high concentrations of these agents produced an unexpected increase in the bone resorption induced by the porins. In contrast, porin-induced bone resorption could be inhibited by relatively high concentrations of the natural inhibitor of interleukin-1 (IL-1 receptor antagonist). It appears that these porins stimulate bone resorption by a mechanism distinct from that of lipopolysaccharide, and the possibility therefore exists that porins play a role in bone destruction in gram-negative bacterial infections of bone.
Meghji
S
S
Division of Surgical Sciences, Eastman Dental Institute, University College London, United Kingdom. S.Meghji@Eastman.ucl.ac.uk
Henderson
B
B
Nair
S P
SP
Tufano
M A
MA
D000818:Animals; D001426:Bacterial Proteins / Q000494:pharmacology*; D001862:Bone Resorption; D002478:Cells, Cultured; D051379:Mice; D018272:Porins / Q000494:pharmacology*; D011550:Pseudomonas aeruginosa / Q000378:metabolism*; D012486:Salmonella typhimurium / Q000378:metabolism*; D012886:Skull / Q000187:drug effects* / Q000473:pathology
D001426:Bacterial Proteins; D018272:Porins